vitiligo
VITILIGO
Vitiligo is an acquired, often familial, melanocytopenic disorder that produces focal depigmentation of the skin.
About half of the patients has onset of lesion before the age of 20.
It is a progressive disease wherein spontaneous repigmentation may occur within 6 months.
Precipitating factors include emotional stress, sunburn, chemical exposure, skin trauma, inflammation, irritation or rash that may precede the lesions by 2-3 months.
Lesions are white-colored macules or patches with well-defined borders and otherwise normal skin surface.

Surgical Intervention

Should only be used in non-progressive, small areas of inactive vitiligo

  • Eg epidermal blister grafting, autologous mini punch grafting, ultrathin epidermal sheet grafting, micropigmentation (tattooing), etc
  • May be an option if topical steroids or photochemotherapy fail to repigment
    • Surgery is usually limited to patients who have segmented or localized disease
    • May be used in some generalized patients
  • The following areas tend not to repigment well:
    • Forehead, hairline, dorsal fingers & ankles
  • Follow surgery w/ phototherapy

Editor's Recommendations
Most Read Articles
15 Dec 2016
New drug applications approved by US FDA as of 1 - 15 December 2016 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
01 Dec 2015
High levels of bacterial vaginosis-associated bacteria during the first trimester were observed in women undergoing miscarriage, a study shows.
01 Dec 2015
Health education counselling decreased the rate of recurrent sexually transmitted infections (STIs) such as gonorrhoea, Chlamydia, and Trichomonas infections in adolescents, based on a retrospective chart review.